Ear infection

disease
On this page

Also known as otitis

Summary

Ear infection (MONDO:0021666) is a disease (an umbrella term covering 5 Mondo subtypes) and 30 clinical trials. Top therapeutic interventions include ciprofloxacin, dexmedetomidine, and montelukast. A subtype of infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 5 Mondo subtypes
  • Clinical trials: 30

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameear infection
Mondo IDMONDO:0021666
MeSHD010031
NCITC27193
UMLSC0699744
MedGen147064
Anatomy (UBERON)UBERON:0001690
Is cancer (heuristic)no

Also known as: Ear infection · otitis

Disease family

This is a subtype of infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious diseaseear infection

Related subtypes (34): infective endocarditis, hirudiniasis, fungal infectious disease, infectious peritonitis, epididymitis, viral infectious disease, bacterial infectious disease, parasitic infectious disease, abscess, Ciliophora infectious disease, hookworm infectious disease, infectious embryofetopathy, mycetoma, infectious disorder of the nervous system, sexually transmitted disease, puerperal infection, Acanthamoeba infectious disease, infectious myositis, infective vaginitis, skin disorder caused by infection, respiratory tract infectious disorder, nail infection, infective arthritis, digestive system infectious disorder, nosocomial infection, eye infectious disorder, prosthesis-related infectious disease, vector-borne disease, coinfection, urinary tract infection, hemorrhagic fever, protothecosis, pythiosis, infectious disease with sepsis

Subtypes (5): viral labyrinthitis, infectious otitis interna, otitis externa, geniculate herpes zoster, infectious otitis media

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 30.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified23
PHASE43
PHASE22
PHASE31
PHASE1/PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00189462PHASE4COMPLETEDA Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children
NCT00654329PHASE4COMPLETEDDexmedetomidine vs Fentanyl for BMT
NCT00765635PHASE4COMPLETEDChlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal
NCT00967317PHASE3UNKNOWNPhase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.
NCT00872209PHASE1/PHASE2COMPLETEDSafety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
NCT01157819PHASE2COMPLETEDSafety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
NCT01359098PHASE2COMPLETEDEfficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa
NCT04471493Not specifiedRECRUITINGPediatric and Ambulatory Research in Infectious Diseases
NCT04743609Not specifiedRECRUITINGRSV Burden in Outpatient and Hospital Settings
NCT05608993Not specifiedACTIVE_NOT_RECRUITINGRELAX: Reducing Length of Antibiotics for Children With Ear Infections
NCT05641285Not specifiedACTIVE_NOT_RECRUITINGDiagnostic Utility of Otosight Middle Ear Scope
NCT05741333Not specifiedACTIVE_NOT_RECRUITINGIn-Office Clinical Study of the Solo+ TTD
NCT06023550Not specifiedRECRUITINGComplicated Infections in Otorhinolaryngology
NCT06034080Not specifiedRECRUITINGInterventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
NCT06429709Not specifiedACTIVE_NOT_RECRUITINGUtility of Advanced Ultrasound Otoscope In The Diagnosis of AOM
NCT07025473Not specifiedNOT_YET_RECRUITINGApplication of the Belle.AI Comparative Image Reference System for Describing Chronic Ear Infections in Pediatric Patients From Low-Resource Communities
NCT00694486Not specifiedCOMPLETEDEustachian Tube Testing in a Pressure Chamber – Validation Study
NCT01033799Not specifiedCOMPLETEDEffect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
NCT01315418Not specifiedTERMINATEDEffect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation
NCT02610699Not specifiedCOMPLETEDCommunity Pediatric Acceptability Study (CPAS)
NCT02723890Not specifiedCOMPLETEDThe Efficacy and Safety of Using the Novel Tyto Device
NCT02831985Not specifiedCOMPLETEDPostoperative Controls of Ventilation Tubes in Children - by General Practitioner or Otolaryngologist?
NCT03101605Not specifiedCOMPLETEDE-learning on the Trainees’ Ability to Diagnose and Treat Acute Otitis Media Among Children
NCT03398044Not specifiedCOMPLETEDAdministration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy
NCT03544138Not specifiedCOMPLETEDIn-Office Study of the Hummingbird® in Children 6 Months-21 Years Old
NCT03722160Not specifiedUNKNOWNClinical Study of the Solo Tympanostomy Tube Device
NCT04148417Not specifiedUNKNOWNClinical Study of the Solo+ Tympanostomy Tube Device
NCT04296448Not specifiedCOMPLETEDEvaluation of Cellphone Based Otoscopy in Pediatric Patients
NCT04483232Not specifiedUNKNOWNAchromobacter Spp: Description of Epidemiology and Resistance in Chronic Ear Infections and in Healthy Individuals.
NCT06781164Not specifiedCOMPLETEDExamination of the Applicability and Performance of Otolaryngology Telemedicine, Telediagnostics in Establishing the Diagnosis and Therapy of Otolaryngology Diseases

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
CIPROFLOXACIN43
DEXMEDETOMIDINE43
MONTELUKAST43
FENTANYL41
SODIUM CHLORIDE41
MEDETOMIDINE31
CHEMBL520512701